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Abstract
Streptococcus pneumoniae causes meningitis, pneumonia, and severe in-
vasive disease (IPD) in young children. Although widespread infant immu-
nisation with the PCV7 seven-valent pneumococcal conjugate vaccine has
led to a dramatic decrease in IPD, infections due to non-vaccine serotypes,
particularly serotype 19A, have increased. As the 19F polysaccharide differs
from 19A at a single linkage position, it was assumed that PCV7 (containing
19F) would cross-protect against 19A disease. However, vaccination with
PCV7 results in only 26% effectiveness against IPD caused by 19A. We ex-
plored the conformations and dynamics of the polysaccharide repeating units
from serotypes 19F and 19A, comparing free energy surfaces for glycosidic
linkages with 100 ns aqueous Molecular Dynamics simulations of the di- and
trisaccharide components. All calculations were performed with both the
CHARMM and the GLYCAM carbohydrate force fields to establish whether
the choice of model affects the predicted molecular behaviour. Although we
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identified key differences between the force fields, overall they were in agree-
ment in predicting a 19F repeating unit with a wider range of conformation
families than the more restricted 19A trisaccharide. This suggests a probable
conformational difference between the 19F and 19A polysaccharides, which
may explain the low cross-protection of 19F vaccines against 19A disease.
Keywords: Streptococcus pneumoniae, vaccine, pneumococcal, force fields,
Molecular Modelling
1. Introduction
The bacterium Streptococcus pneumoniae is a leading cause of meningitis,
pneumonia, febrile bacteremia, osteomyelitis and, less seriously, otitis media,
sinusitis and bronchitis in humans. The greatest impact of pneumococcal in-
vasive disease is on young children: the World Health Organisation estimates
an annual global mortality of 700 000 to 1 000 000 for children under the age
of five and the highest disease burden is in the developing world.1,2 Therefore,
increasing the coverage of vaccination of infants and young children against
pneumococcal disease is a current global health priority.3
The polysaccharide capsule is the main virulence factor of S. pneumoniae
and the target of all pneumococcal vaccines developed thus far. While over
90 pneumococcal serotypes have been described, only a small subset is re-
sponsible for the majority of severe disease.4 Vaccine manufacturers in the
developing world need to select the serotypes to be included in their vaccine
carefully, aiming for a vaccine that covers at least 60% of the invasive disease
isolates in the target region5 and yet has sufficiently low valency (number of
serotypes) to be affordable.
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Pfizer’s 7-valent conjugate vaccine (PCV7) comprises the pneumococcal
serotypes responsible for the majority of disease in the United States prior
to widespread vaccination: serotypes 4, 6B, 9V, 14, 18C, 19F and 23F.6
Since introduction in 2000, PCV7 has dramatically reduced the incidence of
invasive pneumococcal disease7,8, especially for disease due to the vaccine
serotypes. However, the efficacy of PCV7 varies considerably worldwide: it
is highest in the USA and lowest in the developing world.2
Serogroup 19 is currently responsible for the bulk of pneumococcal dis-
ease. This serogroup comprises serotypes 19F, 19A, 19B and 19C, with dis-
ease mainly caused by 19A and 19F.9 When the more stable 19F10 was
selected for PCV7, it was thought that the antibodies elicited would be cross-
protective within the structurally similar serogroup. However, although the
19F and 19A capsular polysaccharides comprise very similar trisaccharide
repeating units —
19F: [→4)-β-d-ManpNAc-(1→4)-α-d-Glcp-(1→2)-α-l-Rhap-(1-P→]
19A: [→4)-β-d-ManpNAc-(1→4)-α-d-Glcp-(1→3)-α-l-Rhap-(1-P→]
— cross-reactivity has proven to be very limited. Indeed, post PCV7 the
proportion of infections caused by serotype 19A has increased: 19A currently
appears to be the most prevalent and resistant pneumococcal serotype.8,11,12
Vaccination with PCV7 has been estimated to result in only 26% effectiveness
against IPD caused by 19A.13
The new higher valency conjugate vaccines aim to provide greater cover-
age of the problematic pneumococcal strains. GSK’s PCV10 adds serotypes
1, 5 and 7F; whereas Pfizer’s PCV13 contains additional serotypes 1, 3, 5,
6A, 7F and 19A. 19A was omitted from PCV10, despite the high levels of
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Figure 1:
disease due to this serotype, because analysis of sera that showed that the
coupling chemistry employed for serotype 19F in PCV10 may provide bet-
ter cross protection against 19A disease.14 Given their recent licensure, the
efficacy of these higher valency vaccines in children is yet to be established.
When considering the molecular basis for cross protection in S. pneumo-
niae serogroup 19, a key question is whether the α(1→3) linkage configuration
in serotype 19A (Fig. 1) alters the molecular conformation sufficiently to af-
fect the binding of 19F antibodies to 19A antigens and hence allow 19A to
evade the host immune response in subjects vaccinated with 19F. Ciuffreda
et al. performed an early computational investigation into the conformation
of serotypes 19A and 19F, using both the hard-sphere HSEA and the MM3
force fields.15 This study found no key differences between the linkages that
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would account for a lack of cross protection between the serotypes. Much
later, Legani et al. employed short Molecular Dynamics simulations (500ps)
with the MM+ force field to indicate whether a carba-analogue of the 19F
repeating unit would have similar conformation and dynamics to the original
repeating unit.16 The two chief determinators of the reliability of MD simula-
tions are conformational sampling and force field accuracy. As both of these
studies employed very short simulations and non-carbohydrate specific force
fields, there is considerable scope for expanding the calculations with modern
force fields with parameters optimised for the treatment of carbohydrates.17
Here we investigate the molecular basis of cross-protection by simulation
of the conformation of the repeating units in the carbohydrate antigens for
pneumococcal serotypes 19A and 19F. We follow a systematic procedure of
investigation, starting with analysis of the preferred conformations of the
individual linkages in the polysaccharides and proceeding to extended sim-
ulations of the two trisaccharides in aqueous solution. In the absence of
experimental data, the reliability of the force field becomes a more pressing
question. Therefore, we performed our calculations both the CHARMM18
and the GLYCAM19 carbohydrate force fields to highlight similarities and
differences between the force fields and thus give a guide to the reliability of
our predictions.
2. Methods
2.1. General Approach
We undertook a systematic, incremental approach to computational anal-
ysis of the repeat units in S. pneumoniae capsular polysaccharide serotypes
5
19A and 19F. Calculation of the preferred conformation of the isolated gly-
cosidic linkages in vacuum (Phase One) progressed to aqueous solution simu-
lations of the disaccharide components (Phase Two) and then, finally, to so-
lution simulations of the trisaccharides (Phase Three). All calculations were
performed twice, firstly with the new CHARMM18 force field and secondly
with the GLYCAM19 force field, to enable comparison of the predictions of
these two carbohydrate models.
2.1.1. Phase One: comparative disaccharide PMF calculations
As saccharide rings are relatively rigid, oligosaccharide conformation is
determined chiefly by the orientations of the glycosidic linkages. Therefore,
in the first phase of analysis, we identified the preferred conformations of the
each of the disaccharide linkages in isolation by calculation of the potential of
mean force (PMF) for rotation about the glycosidic linkage dihedral angles,
φ and ψ. To do this, we divided the 19A and 19F repeat units ( Fig. 1) into
representative disaccharide fragments:
• β-d-ManpNAc-(1→4)-α-d-Glcp (19A and 19F - termed M14G herein)
• α-d-Glcp-(1→2)-α-l-Rhap (19F - termed G12R herein)
• α-d-Glcp-(1→3)-α-l-Rhap (19A - termed G13R herein)
• α-l-Rhap-(1-P→4)-β-d-ManpNAc (19A and 19F - not analysed, force
field parameters not available).
2.1.2. Phase Two: comparative disaccharide solution simulations
The next phase comprised simulations of the key G12R and G13R dis-
accharides in aqueous solution. All simulations were started from conforma-
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tions representing the minimum energy orientations of the individual glyco-
sidic linkages, as identified in Phase One.
2.1.3. Phase Three: comparative trisaccharide PMF calculations
In the final phase, we performed solution simulations of the complete
trisaccharide repeating units for 19F and 19A. Again, simulations were started
from conformations representing the minimum energy orientations of the in-
dividual glycosidic linkages, as identified in Phase One. In addition, the
trisaccharide conformations from the solution molecular dynamics trajecto-
ries were clustered to reveal the principal conformational families explored
during the aqueous simulations.
Neither the CHARMM nor the GLYCAM carbohydrate force fields pa-
rameters currently possess parameters for the highly flexible anomeric phos-
phodiester linkage. While parameters for phosphate substituents were re-
cently added to the CHARMM force field21, these do not extend to flexible
anomeric phosphodiester linkages. Therefore, simulation of more than a sin-
gle repeating unit was not attempted in this study.
2.2. Molecular Dynamics Simulations
All simulations were performed with version 2.9 of the NAMD molecular
dynamics program.22 The force field simulations employed the the CHARMM
carbohydrate parameter set version 1.98 or the GLYCAM06 force field ver-
sion h.
The disaccharide and trisaccharide models were built using psfgen23 struc-
ture building tool for the CHARMM force field simulations and the online
GLYCAM Biomolecular Builder24 for the GLYCAM simulations. To build
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the trisaccharides in CHARMM, it was necessary to first add the ManNAc
residue to CHARMM topology file, using the GlcNAc as a template.25 In
each case, the initial configurations were optimised through 1000 steps of
standard NAMD minimization.
All simulations were preceded by a 10 000 step minimisation phase with a
temperature control and equilibration regime involving 5 K temperature re-
assignments from 0 K culminating in a maximum temperature of 310 K. For
the Molecular Dynamics simulations, equations of motion were integrated
using a Leap-Frog Verlet integrator with a step size of 1 fs. Energy calcula-
tions in the gas phase were performed with an infinite non-bonded cut-off,
while simulations in aqueous-phase employed periodic boundary conditions.
A dielectric constant of unity was employed in all calculations. Long-range
electrostatic interactions were treated using particle mesh Ewald (PME) sum-
mation. Non-bonded interactions were truncated using a switching function
applied between 12.0 and 15.0 A˚ on a neutral group basis (groups correspond
to electrically neutral collections of atoms). For all CHARMM and GLYCAM
simulations, 1-4 interactions were not scaled, according to the force field rec-
ommendations. Simulations were performed under isothermal-isobaric (nPT)
conditions at 310 K maintained using a Langevin piston barostat26 and a
Nose-Hoover27 thermostat.
All solution simulations were carried out with the explicit inclusion of
TIP3P20 water solvent molecules in a periodic cubic unit cell. Carbohy-
drate molecules were solvated with either the GLYCAM Biomolecular Builder
(GLYCAM) or the solvate plugin to the VMD analysis package (CHARMM).
For all the water simulations, box dimensions were adjusted to give a mass
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density of 0.92 g/cm3. The CHARMM disaccharide simulations for G12R
and G13R comprised a single solute disaccharide in a solution box of 464
TIP3P waters (dimensions 25 × 25 × 25 A˚ ) and a PME grid size of 26 in
each dimension. For GLYCAM, G12R was placed in a 29.3 × 29.3 × 29.3
A˚ box of 775 TIP3P waters using a PME grid size of 30 in each dimension;
while G13R was placed in a 29.3 × 29.3 × 29.3 A˚ box of 757 TIP3P waters
with a PME grid size of 30 in each dimension. The simulations of trisac-
charide M14G12R and M14G13R molecules in CHARMM and GLYCAM
all comprised a single saccharide in a box of 4298 TIP3P water molecules,
with 36 A˚ for each dimension of the box and a PME grid size of 36 in each
dimension.
Solution simulations for the disaccharides (G12R and G13R) and cor-
responding trisaccharides (M14G12R and M14G13R) using the CHARMM
and GLYCAM force fields (8 simulations in total) were run for 100 ns each,
where the first 10 ns comprised equilibration and the last 90 ns were used for
data collection.
2.3. Vacuum φ,ψ Potential of Mean Force calculations
Potential of mean force free energy surfaces were calculated with the
metadynamics28 routine incorporated into NAMD22 version 2.9, with the
φ,ψ glycosidic linkage torsion angles used as collective variables. In metady-
namics, the system is simulated by a standard molecular dynamics simulation
to which a special bias potential is progressively added to enhance sampling.
In each case, the (1→X) glycosidic linkage is defined by the torsion angles,
φ = H1′–C1′–O1′–CX and ψ = C1′–O1′–CX–HX. These definitions for φ
and ψ are analogous to φH and ψH in IUPAC convention.
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Metadynamics simulations in vacuum were performed on the M14G, G12R
and G13R disaccharides with both the CHARMM and the GLYCAM carbo-
hydrate force fields using the MD protocol described above. Each metady-
namics simulation comprised a 1500 ns MD simulation, with a Gaussian hill
height of 0.05 kcal/mol and a hill width of 2.5 degrees.
2.4. Post-Simulation Analysis
The 2D PMF files output from NAMD were graphed and contoured using
the gnuplot29 utility. Molecular conformations extracted from the MD sim-
ulations were depicted using the VMD visualization package30 incorporating
the Twister visualization algorithm for carbohydrates31 to highlight the con-
formation of the glycan rings. For the di- and trisaccharide solution time
series plots, frames 2.5 ps apart in the last 90 ns of the run were extracted
and the φ,ψ angles extracted using VMD and plotted on the appropriate
PMF surface. The trisaccharide conformations from the solution molecular
dynamics trajectories were clustered using VMD’s internal measure cluster
command that calculates clusters according to the quality threshold algo-
rithm.32 Clustering was performed with a cut-off of 1.0 on an RMSD fit to
the sugar residue ring atoms and the glycosidic linkage oxygens. Only clus-
ters with prevalence greater than 1% of the simulation time were analysed.
3. Results and Discussion
3.1. Force Field Comparisons: M14G
We start our analysis of pneumococcal capsular polysaccharide confor-
mation with the β-d-ManpNAc-(1→4)-α-d-Glcp disaccharide (M14G) that
10
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is common to 19A and 19F. The contoured φ,ψ PMF surfaces in vacuum for
these linkages (Fig. 2, left column) allow for comparison of the force field
conformational predictions for this linkage. In both the CHARMM (top)
and GLYCAM (bottom) force fields, a central syn-syn well (A) contains
the M14G global minimum, which is at φ,ψ = 51◦,−6◦ in CHARMM and
φ,ψ = 49◦,−14◦ in GLYCAM (indicated by black crosses in Fig. 2). Both
force fields also have a secondary low-energy anti-ψ conformation (B-well) of
similar relative energy, at φ,ψ = 66◦,−151◦ (4∆G = kcal/mol) in CHARMM
and φ,ψ = 54◦,−166◦ (∆G = 4 kcal/mol) in GLYCAM, although the well is
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broader in GLYCAM.
However, although the tertiary minimum (C) has a similar location across
the force fields — at φ,ψ = −71◦,−59◦ (∆G =7 kcal/mol) in CHARMM
and φ,ψ = −71◦,−56◦ (∆G =3 kcal/mol) in GLYCAM — the energy is
4 kcal/mol higher with CHARMM. Force fields have fairly complex fitting
routines and reasons for differences are typically multifactorial (arising from
both bonded and non-bonded interactions) and difficult to pinpoint. How-
ever, a contributing factor for energy differences in well C are interactions
of the aliphatic ring hydrogens on the glucose and mannose residues: the
GLYCAM force field has no partial charges on aliphatic hydrogen atoms,
while in CHARMM aliphatic hydrogens are assigned small partial charges
of 0.09 electrons.17 C-well conformations bring the mannose H2 and the glu-
cose H4 into close proximity - the resultant repulsive Coulombic interactions
in CHARMM would contribute to the raising of the energy of these confor-
mations. Similar H-H interactions would account for the differences in the
high-energy anti-φ minimum conformation (well D) in this disaccharide. In
GLYCAM the D-well is at φ,ψ = 171◦, 6◦ (∆G = 6 kcal/mol), but it is al-
most entirely absent in CHARMM. D-well conformations bring the aliphatic
methyl hydrogens on the N-Acetyl substituent of mannose into close prox-
imity with the glucose ring aliphatic hydrogens.
Despite these differences, the surfaces are very similar, with close agree-
ment on the global and secondary minimum conformations. However, the
broader wells and lowered energy of the C-well in GLYCAM means that sim-
ulations with this force field will show a more flexible M14G disaccharide,
with a broader range of allowed conformations than in CHARMM. Solution
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dynamics of this linkage in the trisaccharide repeating units are discussed
below.
3.2. Force Field Comparisons: G12R and G13R
We continue our analysis with comparisons of the structure and dynamics
for the disaccharides representing the sole point of difference between 19A and
19F : the α-d-Glcp-(1→2)-α-l-Rhap (G13R) versus the α-d-Glcp-(1→3)-α-
l-Rhap (G12R) dimer. Contoured φ,ψ PMF surfaces for these linkages (Fig.
2) enable both comparison of the force field results for a specific linkage
(CHARMM surfaces on the top row and GLYCAM on the bottom) and of the
α(1→2) and α(1→3) linkages (G12R left column, G13R right column). We
first compare the results for the force fields and then progress to a comparison
of the linkages.
3.2.1. G12R (19F)
Vacuum PMFs for the G12R disaccharide, (Fig. 2, left column) produced
with the CHARMM (top) and GLYCAM (bottom) carbohydrate force fields
both reveal that the (1→2) linkage to the axial O2 in l-Rhamnose creates
a relatively flexible dimer: in both surfaces the 4 kcal/mol contour encom-
passes a wide area. The force fields agree on the general location of the global
minimum conformation in the central syn-syn well (A): at φ,ψ = −21◦, 34◦
for CHARMM and φ,ψ = −36◦, 41◦ for GLYCAM. In both CHARMM and
GLYCAM, the minimum energy conformation combines a lack of steric strain
with a stabilising inter-residue O3-O5 hydrogen bonding interaction (shown
for CHARMM in Fig. 2a). The energetic advantage of inter-residue hydro-
gen bonds is expecting to be reduced in aqueous solution.33 The minimum
13
Table 1:
Conformational region
syn-φ/syn-ψ syn-φ/anti-ψ saddle points
A-well C-well B-well X Y
φ, ψ (∆G) φ, ψ (∆G) φ, ψ (∆G) φ, ψ (∆G) φ, ψ (∆G)
G12R
CHARMM -21, 34 (0) 64 64 (5.9) - -34, 114 (8.5) -
-41, -24 (0.7)
GLYCAM -36, 41 (0) 74 56 (2.6) -14, -161 (1.5) -51, 127 (6.9) -39, -119 (4.7)
-41, -19 (0.6)
MM315 -12, 49 (1.3) -
-34, -35 (0)
MM+16 -35, -38 (0) -
G13R
CHARMM -34, -39 (0) 69, 56 (6.7) -29, 171 (2.2) -59 119 (8.2) -51 -134 (6.7)
-28, 43 (1.3)
GLYCAM -14, -54 (0) 66, 51 (4.2) -11, 171 (0.8) -54, 109 (7.5) -56 -119 (7.8)
-36, 16 (0.3)
29, 6 (1.4)
MM315 -36, -40 (0) - -28, 175 (4.3)
-23, 54 (2.0)
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Figure 3:
energy conformation is not a close match with the either the global minimum
previously calculated for the MM3 force field ( φ,ψ = −34◦,−35◦)15 or with
that estimated for the MM+ (φ,ψ = −35◦,−38◦)16 force field (Table 1): in
both these cases the negative ψ region of the A-well was favoured.
In contrast, there is a clear difference for the anti-ψ well in the G12R
PMF’s for the two force fields (labelled B in Fig. 2). GLYCAM has a dis-
tinct secondary minimum energy well (φ,ψ = −14◦,−161◦) and a ∆G = 4.2
kcal/mol barrier (Y) separates the A-well and B-well (Table 1). However, in
the CHARMM force field the A- and B-wells coalesce: the A-well extends in a
long broad valley to the B-region, with no barrier at Y and no clear minimum
at B (the point of lowest energy in this region is at φ,ψ = −41◦,−136◦).
In addition, both force fields predict a small tertiary energy minimum
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(C) — at φ,ψ = 64◦, 64◦ with the CHARMM model and φ,ψ = 74◦, 56◦
with GLYCAM — but it is considerably more favoured in GLYCAM (∆G
= 2.6 kcal/mol versus 5.9 kcal/mol, Table 1). The quaternary syn-φ,anti-ψ
minimum (D) is also much more favoured in GLYCAM (5.2 kcal/mol) than
CHARMM (7.6 kcal/mol). However, in both force fields this minimum is
too high in energy to be extensively explored at standard temperature and
pressure, as is the barrier at X (∆G = 8.5 kcal/mol in CHARMM and 6.9
kcal/mol in GLYCAM). This is demonstrated in the φ,ψ time series of 100
ns unbiased runs in aqueous solution superimposed on the PMF surfaces
(Fig. 3, left column). While the GLYCAM simulation (bottom) shows slight
occupation of the C-well and X-barrier, they are not occupied at all in the
CHARMM simulation.
The time series also shows the effect of the differences in the A- and B-
well’s between the two force fields on G12R disaccharide dynamics. While in
the CHARMM run G12R occupies the extended A-well, including the val-
ley stretching to the B-region, the GLYCAM simulation shows only a small,
distinct B-well population, with little presence on either the X- or Y-saddle
region. Snapshots of anti-ψ conformations in aqueous solution for CHARMM
(φ,ψ = −51◦,−140◦) and GLYCAM (φ,ψ = −178◦,−52◦) are shown in Fig.
3. The low-energy anti-ψ region has few steric clashes and the “flipped” con-
formation brings the equatorial Glc H1 into close proximity with the Rha O5
ring oxygen and, conversely, the Rha H1 into close proximity (≈3 A˚) with the
Glc O5 ring oxygen. This is another instance where Coulombic interactions
involving aliphatic hydrogens play a role. With the small partial charges as-
signed to these groups in CHARMM, pairwise attractive H1-O5 Coulombic
16
interactions will contribute to lowering the the energy of the Y-region con-
formations and, conversely, repulsive H1-H5 and H4-H1 interactions would
raise the energy of tighter B-well conformations, which bring these aliphatic
hydrogens atoms into closer proximity. These interactions are absent in the
GLYCAM force field. Charges on the aliphatic hydrogens also contribute
to the higher energy of the D-well in CHARMM, which brings the Rha H2
and H1 into close contact with the glucose H3 and H5 atoms. Note that,
although aliphatic charges also affect the C6 methyl group in rhamnose, this
does not influence conformations of the G12R disaccharide as the methyl
group is located far away from the glycosidic linkage and is not in contact
with the glucose residue.
3.2.2. G13R (19A)
The φ,ψ free energy maps for the G13R disaccharide (Fig. 2, right col-
umn) produced for the CHARMM (top) and GLYCAM (bottom) force fields
show a closer agreement than is the case for the G12R disaccharide. The cen-
tral syn-syn well (A) contains the global minimum, at φ,ψ = −34◦,−39◦ for
CHARMM and φ,ψ = −14◦,−54◦ for GLYCAM. In both models, this confor-
mation in vacuum is stabilised by an inter-residue hydrogen bond between the
equatorial O2 on the glucose and the axial O2 on the rhamnose residues (Fig.
2b). Both force fields show two conformational regions within the A-well: the
favoured region corresponding to negative ψ values; and a positive ψ region,
corresponding to the global minimum for the α(1→2) linkage. The A-well is
again broader and shallower in GLYCAM, with the secondary local minimum
in the well lower in energy in the GLYCAM model ( φ,ψ = −36◦, 16◦,∆G
= 0.3 kcal/mol,Table 1) than in CHARMM (φ,ψ = −28◦, 43◦,∆G = 1.3
17
kcal/mol). Prior calculations with the HSEA and MM2 force fields esti-
mated the global minimum conformation for G13R at φ,ψ = −36◦,−40◦ 15,
which is close to the CHARMM minimum for this disaccharide.
In contrast to G12R, for G13R the distinct secondary anti-ψ minimum
energy well B appears in both models at approximately the same location:
CHARMM φ,ψ = −29◦, 171◦ and GLYCAM φ,ψ = −11◦, 171◦. However, the
B-well is 1 kcal/mol lower, and hence slightly preferred, in GLYCAM (Fig.
1). Prior molecular mechanics calculations with the MM2 force fields also
identified this B minimum, albeit at a high enthalpy, at φ,ψ = −28◦,−175◦,15
again closest to the CHARMM prediction.
The higher Y-barrier in the G13R disaccharide (6.7 kcal/mol in CHARMM
model and 7.8 kcal/mol in GLYCAM) makes transition to anti-ψ conforma-
tions unlikely at standard temperature and pressure, as is clearly seen in φ,ψ
time series of 100 ns unbiased runs in aqueous solution superimposed on the
PMF surfaces (Fig. 3, right column). Over this time period, no transitions to
the B-well occurring for either force field. The GLYCAM model also shows
increased occupation of the third, tertiary energy minimum at C.
In general, for all the PMF’s calculated here, CHARMM and GLYCAM
show close agreement in the minimum energy conformations identified. How-
ever, there is a general pattern of GLYCAM having broader minimum wells
and secondary minima lower in energy in relative to the global minima than
is the case for CHARMM. This results in more flexible linkages in the GLY-
CAM than in the CHARMM model.
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3.3. Comparison of the 1→2 (19F) and 1→3 (19A) linkages
The early 1992 Molecular Mechanics study with the MM3 force field did
not find a significant difference between the energy surfaces for G12R and
G13R, and predicted that Glc-Rha linkages in general showed rather rigid
conformations.15 The subsequent development of carbohydrate-specific force
fields has altered this picture. Our calculations in both CHARMM and GLY-
CAM indicate that the linkage to the Rhamnose O2 (axial) in G12R results
in fewer steric clashes and a more flexible linkage, with a higher probability
of anti-ψ conformations than is the case for G13R. Both force fields predict
a significant rise of the barriers to rotation to anti-ψ configurations on mu-
tation of an α(1→2) to an α(1→3) glycosidic linkage. This effect is more
pronounced in the CHARMM model, which lacks a clear Y barrier for G12R
and has 6.7 kcal/mol barrier for G13R. The GLYCAM model predicts an ap-
proximate 3 kcal/mol rise in the Y saddle point, to 7.8 kcal/mol in G13R. In
contrast to G12R, for G13R the distinct secondary anti-ψ minimum energy
B-well appears in both models.
The key difference for both force fields is the prevalence of B-well con-
formations in G12R and opposed to G13R: anti- conformations much more
likely in G12R (19A) than G13R (19F). While our vacuum PMF calculations
with both force fields predict a ψ shift of the global energy minimum on mu-
tation of an α(1→2) to an α(1→3) glycosidic linkage into the negative ψ
region, in aqueous solution this shift has little impact: the entire 4 kcal/mol
regions is well occupied for the 90 ns simulations at standard temperature
and pressure.
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3.4. Extension to repeating units: M14G12R and M14G13R
We now explore the aqueous dynamics of the pneumococcal capsular
polysaccharide repeat units in 19F and 19A. Fig. 4 compares the φ,ψ time
series for 90 ns aqueous simulations of the trisaccharide repeating units in
19F (M14G12R, left column) and 19A (M14G13R, right column) with the
CHARMM (top row) and GLYCAM (bottom row) force fields.
As is expected from inspection of the M14G vacuum PMFs, the M14G C-
well (labelled in Fig. 2) is extensively visited in both of the GLYCAM trisac-
charide simulations, but only briefly in the M14G12R CHARMM simulation.
In common with GLYCAM (but not CHARMM), a prior 500 ps MD simula-
tion of the 19F trisaccharide repeating unit in vacuum with the MM+ force
field reported two major conformations of the M14G linkage, at φ,ψ=19◦,-
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51◦ and 43◦,5◦.16 In contrast, M14G B-well anti-ψ conformations are preva-
lent in both CHARMM trisaccharide simulations, but, while the GLYCAM
M14G12R simulation shows anti-ψ populations equal to CHARMM, anti-ψ
M14G conformations only occur briefly in the GLYCAM M14G13R simula-
tion.
From a comparison of Fig. 3 and Fig. 4, it is clear that the addition of
the ManNAc residue to the G12R disaccharide does not affect the dynamics
around the G12R and G13R linkages significantly: the time series are quali-
tatively very similar. Once again, there is good agreement in the behaviour
of the G12R and G13R linkages across the force fields. In both simulations,
the G12R linkage shows a wider range of conformations than the G13R link-
age; neither simulation exhibits anti-ψ conformations for the G13R linkage
(19A). However, there are some differences in the force field simulations for
the G12R linkage in M14G12R. As was the case for the G12R disaccharide,
the trisaccharide in CHARMM explores the long narrow valley extending to
anti-ψ conformations, but does not show the distinct population of anti-ψ
conformations apparent for GLYCAM.
Clustering of the conformations from the trisaccharide aqueous simula-
tions produced the conformational families shown in Fig. 5. For both force
fields, the M14G12R trisaccharide shows a broader range of conformations.
The CHARMM M14G12R simulations (top left) have four conformational
families: a major conformational population representing central A-well con-
formations for both the M14G and G12R linkages (92%, blue), a small sec-
ondary population distinguished by an anti-ψ B-well bend in the M14G link-
age (4%, red), and two minor conformers representing positive (2%, cyan)
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and negative (2%, purple) ψ-bends in the G12R linkage. GLYCAM has five
M14G12R conformational families. Four of these correspond to those seen
for the CHARMM simulations: the major conformational population rep-
resents A-well conformations for both the M14G and G12R linkages (71%,
blue), a secondary population is distinguished by an anti-ψ B-well bend in
the M14G linkage (18%, red) and two minor conformers represent positive
(2%, cyan) and negative (2%, mauve) ψ-bends in the G12R linkage. In addi-
tion, the GLYCAM simulations for M14G12R show a conformational family
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associated with M14G C-well conformations (6%, green), the consequence of
this well being considerably lower in energy in GLYCAM than in CHARMM.
Note that, although the range of conformations is similar for the two force
fields, GLYCAM predicts a lower prevalence of the primary conformation and
a higher prevalence of conformations with anti-ψ B-well bend in the M14G
linkage. Clustering also reveals that, for 19F, large ψ rotations are never
associated with bent “flipped” anti-ψ conformations of the M14G linkage.
For both force fields, the M14G13R trisaccharide is less conformation-
ally varied than the corresponding (1→2)-linked trisaccharide: there are no
significant populations showing anti-ψ conformations for the G13R linkage.
For the M14G12R CHARMM simulation, only two principle populations are
seen: a major conformational population representing central A-well con-
formations for both the M14G and G12R linkages (89%, blue) and a small
secondary population distinguished by an anti-ψ B-well bend in the M14G
linkage (11%, red). In the GLYCAM simulation, none of the principle pop-
ulations show “flipped” anti-ψ conformations of the M14G linkage. There
is the usual major conformational population representing A-well conforma-
tions for both the M14G and G12R linkages (90%, blue), a conformational
family associated with M14G C-well conformations as seen for M14G12R
(7%, green), and an additional conformational family associated with M14G
conformations in the upper-right corner of the A-well (2%, yellow).
Thus, the primary difference between the force fields is a distinct popula-
tion in both the GLYCAM simulations associated with C-well conformations
of the M14G linkage. Such conformations do not occur in the CHARMM
trisaccharide simulations. In general, the GLYCAM force field shows more
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flexible linkages with a wider range of conformations than CHARMM. How-
ever, despite this, the conformation families predicted by the CHARMM
and GLYCAM force fields are remarkably similar. The principle difference
between the M14G12R and M14G13R trisaccharides in both force fields is
that M14G12R has a much wider range of conformations than M14G13R.
M14G12R has two families of “bent” conformations of the G12R linkage
(the cyan and purple conformations in the left column of Fig. 5), which
do not occur for the G13R linkage. These conformations, if prevalent in a
polysaccharide, would result in a bend at the point of the phosphodiester
linkage. However, because of the great flexibility of the phosphodiester link-
age, the affect of such a bend on polysaccharide conformation is difficult to
predict. Factors to be considered are the potential for intra-chain hydropho-
bic interactions with the aliphatic methyl group and potential counter-ion
interactions with the charged phosphate group.
4. Conclusions and Future Work
We performed conformational analysis of the repeating units in pneu-
mococcal capsular polysaccharides serotypes 19A and 19F. Our calculations
reveal clear differences in the allowed conformations of serotypes 19A and 19F
trisaccharide repeating units, with the Glcp-(1→2)-α-l-Rhap linkage show-
ing “bent” conformational families that do not occur for the Glcp-(1→3)-
α-l-Rhap linkage. This is in contrast to previous modelling studies, which
predicted no significant difference between the linkages. This difference in
conformational preference could result a change in molecular conformation
significant enough to affect binding of the antibody to the polysaccharide
24
antigen and thus account for the lack of cross-protection of serotype 19F
vaccination against serotype 19A.
It is encouraging that the CHARMM and GLYCAM carbohydrate force
fields showed close agreement in the minimum energy conformations identi-
fied. However, generally GLYCAM exhibited more flexible glycosidic link-
ages, with broader minimum wells and secondary minima lower in energy in
relative to the global minima than was the case for CHARMM. Small charges
on the aliphatic hydrogens present in CHARMM, but not in GLYCAM, can
account for some of the differences seen for the linkages examined here.
This work represents the first stage in analysis of a complex system and
the effect of the flexible phosphodiester linkages and counter-ions, inter-
residue interactions and increasing chain length have still to be determined,
once suitable force field parameters for the phosphodiester linkage are avail-
able in CHARMM or GLYCAM carbohydrate force fields. In addition, de-
pending on availability of suitable samples, predicted conformations could be
validated by use of NMR spectroscopy.
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Figure and Table Captions
Table 1. Values of the φ,ψ dihedral angles (degrees) for local minima and
saddle points on the PMF surfaces for the G12R and G13R disaccha-
rides. Approximate free energy values (in kcal/mol) relative to the
global energy minimum are quoted in parenthesis. Values from prior
Molecular Mechanics studies are included, but here energies denote
enthalpies, not free energy.
Figure 1. Schematic diagram of the trisaccharide repeating units of the cap-
sular polysaccharides in pneumococcal serotypes 19F and 19A.
19F: [→4)-β-d-ManpNAc-(1→4)-α-d-Glcp-(1→2)-α-l-Rhap-(1-P→]
19A: [→4)-β-d-ManpNAc-(1→4)-α-d-Glcp-(1→3)-α-l-Rhap-(1-P→]
Figure 2. Contoured disaccharide φ,ψ PMF surfaces in vacuum produced
with the CHARMM (top) and GLYCAM (bottom) carbohydrate force
fields: M14G (common to 19A/19F, left column), G12R (middle col-
umn) and G13R (right column). Contours are drawn at 2 kcal/mol
intervals, to a maximum cut-off of 12 kcal/mol. Locations of the global
energy minima are indicated by black crosses. Minimum energy re-
gions are labeled A through D and the X- and Y-saddle points are also
indicated for G12R and G13R. Structures shown are snapshots of the
G12R and G13R disaccharides in A-well minimum energy conforma-
tions taken from a vacuum simulation with the CHARMM force field.
The φ and ψ labels on the glycosidic linkage identify the central bond
in these dihedral angles. (a) G12R (19F): φ,ψ = −21◦, 34◦. (b) G13R
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(19A): φ,ψ = −34◦,−39◦. Stabilising hydrogen bonding interactions
are indicated by dashed lines.
Figure 3. Scatterplots of the φ,ψ time series for 90 ns unbiased runs in aque-
ous solution with the G12R (left column) and G13R (right column)
disaccharides using the CHARMM (top row) and GLYCAM (bottom
row) force fields. Scatter plots are superimposed on the corresponding
vacuum PMF surfaces. Molecular structures shown are snapshots of
the G12R disaccharide in B-well anti conformations taken from aque-
ous solution simulations. Stabilising hydrogen bonding interactions are
indicated by dashed lines. The φ and ψ labels on the glycosidic linkage
identify the central bond in these dihedral angles. (a) CHARMM con-
formation with φ,ψ = −51◦,−140◦. (b) GLYCAM conformation with
φ,ψ = −178◦,−52◦.
Figure 4. Scatterplots for 90 ns unbiased runs in aqueous solution of the φ,ψ
time series in both linkages of the of the capsular polysaccharide trisac-
charide repeating units in pnuemococcal serotypes 19F (M14G12R, left
column) and 19A (M14G13R, right column) using the CHARMM (top
row) and GLYCAM (bottom row) force fields. Scatter plots are super-
imposed on the corresponding vacuum PMF surfaces.
Figure 5. Comparison of representative structures from the principle con-
formational families formed in solutions simulations of the trisaccharide
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repeating units in 19F (left column) and 19A (right column) using the
CHARMM (top row) and GLYCAM (bottom row) carbohydrate force
fields. The φ,ψ time series in the M14G and G12R/G13R linkages are
indicated on the corresponding PMF surfaces. The principle cluster
is shown in blue, followed by secondary clusters in descending order
in red, green, cyan and purple. Population percentages of each of the
clusters during the simulation are shown.
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